# Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction

> **NCT02098629** · PHASE2 · COMPLETED · sponsor: **Shantou University Medical College** · enrollment: 25 (actual)

## Conditions studied

- Myocardial Reperfusion Injury

## Interventions

- **DRUG:** Milrinone
- **DRUG:** Esmolol
- **DRUG:** Saline Infusion

## Key facts

- **NCT ID:** NCT02098629
- **Lead sponsor:** Shantou University Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2023-03
- **Final completion:** 2024-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02098629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02098629, "Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02098629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*